Page last updated: 2024-10-30

edaravone and Allergic Encephalomyelitis

edaravone has been researched along with Allergic Encephalomyelitis in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to evaluate therapeutic potential of edaravone in the murine model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE) and to expand the knowledge of its mechanism of action."8.12Edaravone attenuates disease severity of experimental auto-immune encephalomyelitis and increases gene expression of Nrf2 and HO-1. ( Hrnčíř, T; Hroudová, J; Kübra Öztürk, H; Kučera, T; Kutinová Canová, N; Ľupták, M; Michaličková, D; Šíma, M; Slanař, O, 2022)
"The aim of this study was to evaluate therapeutic potential of edaravone in the murine model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE) and to expand the knowledge of its mechanism of action."4.12Edaravone attenuates disease severity of experimental auto-immune encephalomyelitis and increases gene expression of Nrf2 and HO-1. ( Hrnčíř, T; Hroudová, J; Kübra Öztürk, H; Kučera, T; Kutinová Canová, N; Ľupták, M; Michaličková, D; Šíma, M; Slanař, O, 2022)
"Treatment with edaravone significantly ameliorated the clinical severity of EAE, and a reduced infiltration of lymphocytes was observed based on a histological analysis."1.35Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis. ( Kinoshita, M; Kumanogoh, A; Kusunoki, S; Miyamoto, K; Moriya, M; Nakatsuji, Y; Okuno, T; Sakoda, S, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Michaličková, D1
Kübra Öztürk, H1
Hroudová, J1
Ľupták, M1
Kučera, T1
Hrnčíř, T1
Kutinová Canová, N1
Šíma, M1
Slanař, O1
Moriya, M1
Nakatsuji, Y1
Miyamoto, K1
Okuno, T1
Kinoshita, M1
Kumanogoh, A1
Kusunoki, S1
Sakoda, S1

Other Studies

2 other studies available for edaravone and Allergic Encephalomyelitis

ArticleYear
Edaravone attenuates disease severity of experimental auto-immune encephalomyelitis and increases gene expression of Nrf2 and HO-1.
    Physiological research, 2022, 03-25, Volume: 71, Issue:1

    Topics: Animals; Edaravone; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Gene Expression;

2022
Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis.
    Neuroscience letters, 2008, Aug-08, Volume: 440, Issue:3

    Topics: Animals; Antipyrine; Calcium-Binding Proteins; CD3 Complex; Cell Line, Transformed; Disease Models,

2008